Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Bregni · SciRah

Researcher profile · Semantic Scholar

G. Bregni

Share profile

G. Bregni — researcher profile on SciRah

h-index: 14
Works: 68
Citations: 659

Most-cited papers

Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials.
E. Giunta, G. Bregni, A. Pretta, A. Deleporte +7 more
2021Cancer Treatment Reviews59 citations
Semantic Scholar
Better Together: Targeted Combination Therapies in Breast Cancer.
E. Zanardi, G. Bregni, F. De Braud, S. Di Cosimo
2015Seminars in Oncology53 citations
Semantic Scholar
PD-1 and PD-L1 inhibitors in oesophago-gastric cancers.
T. Telli, G. Bregni, S. Camera, A. Deleporte +2 more
2020Cancer Letters50 citations
Semantic Scholar
Regorafenib in combination with immune checkpoint inhibitors for mismatch repair proficient (pMMR)/microsatellite stable (MSS) colorectal cancer.
Tuğba Akın Telli, G. Bregni, Michele Vanhooren, Rita Saude Conde +2 more
2022Cancer Treatment Reviews39 citations
Semantic Scholar
HER2 Amplification and Anti-EGFR Sensitivity in Advanced Colorectal Cancer.
G. Bregni, S. Sciallero, A. Sobrero
2019JAMA Oncology36 citations
Semantic Scholar
Adjuvant chemotherapy for gastric cancer: current evidence and future challenges.
R. Miceli, G. Tomasello, G. Bregni, M. Di Bartolomeo +1 more
2014World Journal of Gastroenterology35 citations Open access
Semantic Scholar
EORTC consensus recommendations on the optimal management of colorectal cancer liver metastases.
G. Bregni, Richard A. Adams, R. Bale, M. Bali +47 more
2025Cancer Treatment Reviews30 citations Open access
Semantic Scholar
Prognostic and predictive molecular biomarkers in metastatic renal cell carcinoma patients treated with immune checkpoint inhibitors: a systematic review
S. E. Rebuzzi, F. Perrone, M. Bersanelli, G. Bregni +2 more
2019Expert Review of Molecular Diagnostics29 citations
Semantic Scholar
Platinum salts in advanced breast cancer: a systematic review and meta-analysis of randomized clinical trials
F. Petrelli, S. Barni, G. Bregni, F. De Braud +1 more
2016Breast Cancer Research and Treatment26 citations
Semantic Scholar
Body Mass Index and Clinical Benefit of Fulvestrant in Postmenopausal Women with Advanced Breast Cancer
Arpine H. Gevorgyan, G. Bregni, G. Galli, M. Ganzinelli +7 more
2016Tumori26 citations
Semantic Scholar
HER2-Positive Neuroendocrine Breast Cancer: Case Report and Review of Literature
Arpine H. Gevorgyan, G. Bregni, G. Galli, E. Zanardi +2 more
2016Breast Care22 citations Open access
Semantic Scholar
Circulating Biomarkers in Advanced Colorectal Cancer Patients Randomly Assigned to Three Bevacizumab-Based Regimens
A. Martinetti, R. Miceli, E. Sottotetti, M. Di Bartolomeo +8 more
2014Cancers20 citations Open access
Semantic Scholar
The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO
S. Di Cosimo, C. Campbell, H. A. Azim, G. Galli +17 more
2017European Journal of Cancer18 citations Open access
Semantic Scholar
Tackling Refractory Metastatic Colorectal Cancer: Future Perspectives
N. Personeni, V. Smiroldo, E. Giunta, M. G. Prete +3 more
2021Cancers14 citations Open access
Semantic Scholar
Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance
Pashalina Kehagias, N. Kindt, Mohammad Krayem, Ahmad Najem +8 more
2022Cells13 citations Open access
Semantic Scholar
Neoadjuvant Chemotherapy Exerts Selection Pressure Towards Luminal Phenotype Breast Cancer
G. Galli, G. Bregni, S. Cavalieri, L. Porcu +12 more
2017Breast Care13 citations Open access
Semantic Scholar
Pre-trial quality assurance of diffusion-weighted MRI for radiomic analysis and the role of harmonisation.
Z. Paquier, Shih-Li Chao, G. Bregni, A. V. Sánchez +7 more
2022Physica medica (Testo stampato)12 citations Open access
Semantic Scholar
Toward Targeted Therapies in Oesophageal Cancers: An Overview
G. Bregni, Benjamin Beck
2022Cancers11 citations Open access
Semantic Scholar
The urgent need to improve the tools to assess clinical benefit and value of cancer treatment.
A. Sobrero, A. Puccini, G. Bregni, P. Bruzzi
2017European Journal of Cancer11 citations
Semantic Scholar
Trastuzumab Cardiac Toxicity: A Problem we Put our Heart Into
G. Bregni, G. Galli, Arpine H. Gevorgyan, F. De Braud +1 more
2016Tumori11 citations
Semantic Scholar
Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer
G. Bregni, C. Vandeputte, A. Pretta, C. Senti +21 more
2021Acta oncologica10 citations Open access
Semantic Scholar
Prognostic Value of the Pace of Tumor Progression as Assessed by Serial 18F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial
S. Camera, Tuğba Akın Telli, E. Woff, C. Vandeputte +16 more
2020Cancers10 citations Open access
Semantic Scholar
Immunotherapy beyond progression in advanced renal cell carcinoma: a case report and review of the literature.
S. E. Rebuzzi, G. Bregni, M. Grassi, A. Damiani +3 more
2018Immunotherapy10 citations
Semantic Scholar
Circulating DNA in the neoadjuvant setting of early stage colon cancer
G. Bregni, A. Pretta, C. Senti, Elena Acedo Reina +22 more
2022Acta oncologica8 citations Open access
Semantic Scholar
MOMENTUM: A Phase I Trial Investigating 2 Schedules of Capecitabine With Aflibercept in Patients With Gastrointestinal and Breast Cancer.
S. Camera, A. Deleporte, G. Bregni, Elena Trevisi +10 more
2020Clinical colorectal cancer8 citations
Semantic Scholar
Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis.
G. Rosati, F. Galli, M. Cantore, F. Bergamo +17 more
2020The Oncologist8 citations Open access
Semantic Scholar
Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel
G. Bregni, Tiberio Sticca, S. Camera, Tuğba Akın Telli +18 more
2020Acta oncologica6 citations Open access
Semantic Scholar
Cisplatin-related Atrial Fibrillation during PEB Chemotherapy for Testicular Seminoma: A Case Report
A. Pastorino, G. Bregni
20166 citations Open access
Semantic Scholar
Clinical trials for older cancer patients: A systematic review.
R. Fazio, A. Audisio, G. Bregni, D. Sur +10 more
2025Cancer Treatment Reviews5 citations
Semantic Scholar
Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysis.
G. Bregni, B. Leurquin, P. Giasafaki, N. Takemura +14 more
2025European Journal of Cancer5 citations
Semantic Scholar
Complete remission in metastatic breast cancer: expecting the unexpected—results of a cross-sectional study
G. Galli, A. Tessari, L. Porcu, G. Bregni +7 more
2017Breast Cancer5 citations
Semantic Scholar
Prognosis of women with early breast cancer and PIK3CA mutations.
S. Di Cosimo, G. Bianchi, G. Bregni, F. De Braud
2015Breast5 citations Open access
Semantic Scholar
JCOG0603: Are We Really Sure This Was a Negative Trial?
Rita Saude Conde, G. Bregni, E. Saad, A. Hendlisz +1 more
2022Journal of Clinical Oncology4 citations
Semantic Scholar
Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial.
C. Vandeputte, G. Bregni, Paraskevas Gkolfakis, T. Guiot +20 more
2021Clinical colorectal cancer4 citations Open access
Semantic Scholar
505TiP REGINA: A phase II trial of neoadjuvant regorafenib (rego) in combination with nivolumab (nivo) and short-course radiotherapy (SCRT) in intermediate-risk, stage II-III rectal cancer (RC)
G. Bregni, C. Senti, E. Reina, Paraskevas Gkolfakis +15 more
2021Annals of Oncology4 citations Open access
Semantic Scholar
Treatment compliance in early stage anal cancer.
A. Pretta, Elena Trevisi, G. Bregni, A. Deleporte +2 more
2020Annals of Oncology4 citations Open access
Semantic Scholar
The Optimal Duration of Adjuvant Therapy for Stage III Colon Cancer: the European Perspective
G. Bregni, S. E. Rebuzzi, A. Sobrero
2019Current Treatment Options in Oncology4 citations
Semantic Scholar
Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer
C. Cardone, E. Martinelli, T. Troiani, V. Sforza +14 more
2019ESMO Open4 citations Open access
Semantic Scholar
SHIP2–PLK1 crosstalk promotes sensitivity to dual inhibition in esophageal squamous cell carcinoma
Ana Raquel Ramos, G. Bregni, Nadia Gillet, K. Ando +9 more
2025Molecular Cancer3 citations Open access
Semantic Scholar
PD-L1 Expression in Paired Samples of Rectal Cancer
Mina Coussement, R. Fazio, A. Audisio, Reem El Khoury +15 more
2024Cancers3 citations Open access
Semantic Scholar
Mind the target: human epidermal growth factor receptor 2 in colorectal cancer
R. Saúde-Conde, G. Rasschaert, G. Bregni, A. Hendlisz +1 more
2022Current Opinion in Oncology2 citations
Semantic Scholar
Anal squamous cell carcinoma: standards of care, new data and ongoing clinical trials
E. Giunta, G. Bregni, A. Hendlisz, F. Sclafani
2021Current Opinion in Oncology2 citations
Semantic Scholar
PD-9 Universal screening for Lynch syndrome: Reflex testing to improve appropriateness of genetic counseling and diagnosis
A. Puccini, A. Damiani, L. Varesco, S. Zupo +7 more
20202 citations Open access
Semantic Scholar
Axillary nodal involvement by primary tumor features in early breast cancer: an analysis of 2600 patients
M. D. De Santis, E. La Rocca, E. Meneghini, G. Bregni +12 more
2019Clinical and Translational Oncology2 citations
Semantic Scholar
The Amount of Evidence Needed to Support ERBB2 as a Biomarker for Resistance to EGFR Inhibitors in Metastatic Colorectal Cancer-In Reply.
G. Bregni, S. Sciallero, A. Sobrero
2019JAMA Oncology2 citations
Semantic Scholar
Breast cancer Ki67, tumor size and axillary nodes relationship: it's complicated
G. Bregni, E. Meneghini, G. Galli, S. Cavalieri +7 more
20162 citations Open access
Semantic Scholar
Disease progression pattern in metastatic breast cancer patients treated with anti-HER2 therapies
D. Serpico, L. Porcu, A. Tessari, Arpine H. Gevorgyan +5 more
2015Clinical and Translational Oncology2 citations
Semantic Scholar
Current trends of clinical trials for older patients with cancer: A systematic review.
R. Fazio, A. Audisio, E. Saad, G. Bregni +10 more
2024Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Pre-existing evidence and outcome of phase III trials in gastrointestinal oncology: a systematic review.
G. Bregni, Elena Trevisi, Rita Saúde Conde, Michele Vanhooren +5 more
2023Journal of the National Cancer Institute1 citations Open access
Semantic Scholar
Adjuvant therapy for high-risk endometrial cancer
G. Damiano, F. Barra, M. L. Iaia, G. Bregni +2 more
20181 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Sclafani×18
Invite
F. Sclafani — researcher profile on SciRah
A. Hendlisz×16
Invite
A. Hendlisz — researcher profile on SciRah
F. De Braud×12
Invite
F. De Braud — researcher profile on SciRah
S. Di Cosimo×12
Invite
S. Di Cosimo — researcher profile on SciRah

×10

Invite

A. Deleporte — researcher profile on SciRah

Invite

A. Pretta — researcher profile on SciRah

Invite

G. Galli — researcher profile on SciRah

Elena Trevisi×7

Invite

Elena Trevisi — researcher profile on SciRah

Pashalina Kehagias×6

Invite

Pashalina Kehagias — researcher profile on SciRah

Invite

C. Senti — researcher profile on SciRah

Invite

F. Sclafani — researcher profile on SciRah

Arpine H. Gevorgyan×5

Invite

Arpine H. Gevorgyan — researcher profile on SciRah